📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Omni Biopharma

1.1 - Company Overview

Omni Biopharma Logo

Omni Biopharma

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of Alpha-1 antitrypsin (AAT)-based therapeutics, developing alternative uses of AAT for various medical treatments and advancing recombinant forms of AAT for therapeutic applications.

Products and services

  • Recombinant Forms of AAT: Engineers custom-engineered recombinant Alpha-1 antitrypsin constructs for therapeutic applications, supporting development of treatments and alternative clinical uses of AAT
  • Alpha-1 Antitrypsin (AAT) Treatments: Develops application-specific alternative uses of AAT for medical treatments, investigating new therapeutic contexts and clinical applications of AAT

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Omni Biopharma

Medarex Logo

Medarex

HQ: United States Website
  • Description: Provider of fully human antibody-based therapeutics, focused on discovering, developing and commercializing treatments for life-threatening and debilitating diseases, including cancer, inflammation, autoimmune disorders and infectious diseases, leveraging its UltiMAb technology.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Medarex company profile →
CTI Science Logo

CTI Science

HQ: United States Website
  • Description: Provider of biotechnology research and development focused on improving human and animal health, developing a flagship product for submission for regulatory drug approval. Founded in 2007 by Dr. Boyd E. Haley, based in Lexington, Kentucky, United States.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CTI Science company profile →
Microvascular Tissues Logo

Microvascular Tissues

HQ: United States Website
  • Description: Provider of biological vascular tissues for implantation, including mVASC Microvascular Tissue, a sterile, off-the-shelf human microvascular tissue graft designed to restore blood flow and support natural healing in damaged tissues.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Microvascular Tissues company profile →
Precigen Logo

Precigen

HQ: United States Website
  • Description: Provider of bio-therapeutic control systems and platforms to minimize toxicity, including UltraCAR-T, a non-viral multigenic CAR-T cell therapy enabling rapid manufacturing with enhanced in vivo persistence and tumor response; ActoBiotics, microbe-based agents delivering disease-modifying treatments locally; and Exemplar Genetics gene-edited minipig models and preclinical services.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Precigen company profile →
Saniona Logo

Saniona

HQ: Denmark Website
  • Description: Provider of pharmaceutical research and development focused on advancing multiple potential new medicines through clinical trials and pioneering highly selective ion channel modulators, leveraging a well-established approach to disease treatment.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Saniona company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Omni Biopharma

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Omni Biopharma

2.2 - Growth funds investing in similar companies to Omni Biopharma

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Omni Biopharma

4.2 - Public trading comparable groups for Omni Biopharma

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Omni Biopharma

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Omni Biopharma

What does Omni Biopharma do?

Omni Biopharma is a provider of Alpha-1 antitrypsin (AAT)-based therapeutics, developing alternative uses of AAT for various medical treatments and advancing recombinant forms of AAT for therapeutic applications.

Who are Omni Biopharma's competitors?

Omni Biopharma's competitors and similar companies include Medarex, CTI Science, Microvascular Tissues, Precigen, and Saniona.

Where is Omni Biopharma headquartered?

Omni Biopharma is headquartered in United States.

How many employees does Omni Biopharma have?

Omni Biopharma has 1,000 employees 🔒.

When was Omni Biopharma founded?

Omni Biopharma was founded in 2010 🔒.

What sector and industry vertical is Omni Biopharma in?

Omni Biopharma is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Omni Biopharma

Who are the top strategic acquirers in Omni Biopharma's sector and industry

Top strategic M&A buyers and acquirers in Omni Biopharma's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Omni Biopharma?

Top strategic M&A buyers groups and sectors for Omni Biopharma include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Omni Biopharma's sector and industry vertical

Which are the top PE firms investing in Omni Biopharma's sector and industry vertical?

Top PE firms investing in Omni Biopharma's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Omni Biopharma's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Omni Biopharma's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Omni Biopharma's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Omni Biopharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Omni Biopharma's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Omni Biopharma?

The key public trading comparables and valuation benchmarks for Omni Biopharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Omni Biopharma for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Omni Biopharma with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Omni Biopharma's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Omni Biopharma with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Omni Biopharma's' sector and industry vertical?

Access recent funding rounds and capital raises in Omni Biopharma's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Omni Biopharma